Citations 7

Treatment of MOG-IgG-associated demyelination with Rituximab: a multinational study of 98 patients (S13.003)

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.s13.003

Hormonal Exposures Relate to Clinical Phenotype in Women with Neuromyelitis Optica (S12.005)

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.s12.005

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders

Brain | March 6, 2019 | Volume: 142 | Issue: 5 | Pages: 1310-1323

10.1093/brain/awz054 | PMID 30938427

Area postrema syndrome

Neurology | September 26, 2018 | Volume: 91 | Issue: 17 | Pages: No page available

10.1212/wnl.0000000000006392 | PMID 30258024

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

Neurology | June 19, 2015 | Volume: 85 | Issue: 2 | Pages: 177-189

10.1212/wnl.0000000000001729 | PMID 26092914

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder

JAMA Neurology | May 26, 2015 | Volume: 72 | Issue: 7 | Pages: 815

10.1001/jamaneurol.2015.0248 | PMID 26010909

Letter To the Editor

Multiple Sclerosis Journal | March 15, 2007 | Volume: 13 | Issue: 5 | Pages: 686-686

10.1177/1352458507072190 | PMID 17548454